Fingerling - the EPS was a loss of 16.58c / share. There is a deficiency of working capital - see note 1 on page 29. Need some clarity of where this is heading.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025